Trial Profile
Dose Down Of Omalizumab Induced Asthma Exacerbation Within 24 Weeks
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2014
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 13 Oct 2014 New trial record